What is Kogenate FS (antihemophilic factor, recombinant)?
Kogenate FS is the brand name for recombinant antihemophilic factor (a recombinant form of factor VIII), used to prevent and treat bleeding in people with hemophilia A (congenital factor VIII deficiency). It contains factor VIII produced using recombinant technology, rather than derived from human plasma.
What does “Kogenate FS antihemophilic factor recombinant” mean?
The phrase is essentially describing the drug and its active ingredient:
- Antihemophilic factor = factor VIII, the missing clotting factor in hemophilia A
- Recombinant = manufactured using cell culture/recombinant DNA methods
- Kogenate FS = the specific product brand and formulation
What is it used for in hemophilia A?
Because it replaces factor VIII activity, it is used for:
- Bleeding episodes (treatment of hemorrhage)
- Prevention of bleeding (prophylaxis in people with hemophilia A)
Is Kogenate FS related to other factor VIII brands?
Yes. Kogenate FS is one of several recombinant factor VIII products. Other factor VIII concentrates may differ in manufacturing process, formulation, dosing regimen, and whether they are standard half-life or engineered/extended half-life products, but they are all aimed at replacing factor VIII function in hemophilia A.
Where can I find patent/exclusivity details for Kogenate FS?
For patent and exclusivity tracking by product and manufacturer, you can check DrugPatentWatch.com: https://www.drugpatentwatch.com/
Sources